Insider Trading activities of Enanta Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Enanta Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Enanta Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Enanta Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is ENTA. The reporting company's CIK number is 1177648.
The total value of stock buying since 2005 is $5,071,607.
The total value of stock sales since 2005 is $53,504,715.
The total value of stock option exercises since 2005 is $1,211,415.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Enanta Pharmaceuticals Inc (ENTA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-04 0 $0 0 $0 29,274 $87,060
2017-01 0 $0 13,921 $488,501 0 $0
2016-11 0 $0 13,921 $437,606 0 $0
2016-06 0 $0 0 $0 41,645 $123,852
2016-05 500 $12,222 0 $0 25,000 $74,350
2016-03 0 $0 0 $0 18,561 $47,200
2016-02 2,000 $54,080 0 $0 0 $0
2016-01 0 $0 0 $0 121,487 $278,457
2015-11 0 $0 6,000 $187,368 0 $0
2015-10 0 $0 7,500 $300,742 68,700 $102,912
2015-09 0 $0 7,500 $298,350 0 $0
2015-08 0 $0 11,250 $490,470 0 $0
2015-07 0 $0 11,250 $521,895 0 $0
2015-06 0 $0 22,000 $929,737 0 $0
2015-05 0 $0 32,000 $1,252,144 0 $0
2015-03 0 $0 15,000 $510,390 0 $0
2015-02 2,400 $80,481 15,000 $530,295 0 $0
2015-01 0 $0 19,500 $981,796 58,004 $70,010
2014-12 0 $0 15,000 $689,625 7,055 $5,171
2014-11 0 $0 21,000 $927,876 0 $0
2014-10 0 $0 4,000 $181,180 0 $0
2014-09 0 $0 10,000 $401,629 0 $0
2014-08 1,000 $38,950 15,000 $590,075 11,149 $14,415
2014-07 0 $0 25,000 $1,016,115 0 $0
2014-06 0 $0 5,000 $188,800 0 $0
2014-05 0 $0 5,000 $183,795 0 $0
2014-04 0 $0 25,000 $998,700 0 $0
2014-03 0 $0 459,334 $17,833,781 92,132 $67,532
2014-02 0 $0 379,944 $14,946,840 0 $0
2014-01 0 $0 5,800 $163,507 380,206 $278,690
2013-12 0 $0 21,861 $749,074 0 $0
2013-11 0 $0 50,000 $1,287,728 0 $0
2013-10 0 $0 266,508 $6,085,937 0 $0
2013-09 0 $0 14,300 $330,759 0 $0
2013-07 0 $0 0 $0 84,265 $61,766
2013-03 348,991 $4,885,874 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Enanta Pharmaceuticals Inc insiders (ENTA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-04-11 Mellett Paul J (Treasurer and CFO) Option Ex 29,274 2.97 87,060
2017-01-04 Or Yat Sun (Chief Scientific Officer) Sale 13,921 35.09 488,501
2016-11-29 Or Yat Sun (Chief Scientific Officer) Sale 13,921 31.43 437,606
2016-06-10 Luly Jay R. (President and CEO) Option Ex 41,645 2.97 123,852
2016-05-11 Gardiner Nathaniel S. (Sr. VP & General Counsel) Buy 500 24.45 12,222
2016-05-10 Luly Jay R. (President and CEO) Option Ex 25,000 2.97 74,350
2016-03-09 Luly Jay R. (President and CEO) Option Ex 18,561 2.54 47,200
2016-02-12 Vance Terry (Director) Buy 2,000 27.04 54,080
2016-01-19 Or Yat Sun (Chief Scientific Officer) Option Ex 42,922 2.54 109,150
2016-01-04 Or Yat Sun (Chief Scientific Officer) Option Ex 78,565 2.15 169,307
2015-11-24 Mellett Paul J (Treasurer and CFO) Sale 6,000 31.23 187,368
2015-10-23 Luly Jay R. (President and CEO) Option Ex 68,700 1.50 102,912
2015-10-15 Mellett Paul J (Treasurer and CFO) Sale 7,500 40.10 300,742
2015-09-08 Mellett Paul J (Treasurer and CFO) Sale 7,500 39.78 298,350
2015-08-10 Or Yat Sun (Chief Scientific Officer) Sale 3,750 42.96 161,100
2015-08-07 Mellett Paul J (Treasurer and CFO) Sale 7,500 43.92 329,370
2015-07-13 Or Yat Sun (Chief Scientific Officer) Sale 3,750 46.40 174,000
2015-07-13 Mellett Paul J (Treasurer and CFO) Sale 7,500 46.39 347,895
2015-06-11 Or Yat Sun (Chief Scientific Officer) Sale 3,750 42.47 159,266
2015-06-11 Mellett Paul J (Treasurer and CFO) Sale 7,500 42.51 318,810
2015-06-05 Or Yat Sun (Chief Scientific Officer) Sale 10,750 42.02 451,661
2015-05-19 Mellett Paul J (Treasurer and CFO) Sale 24,000 40.13 963,096
2015-05-11 Or Yat Sun (Chief Scientific Officer) Sale 8,000 36.13 289,048
2015-03-09 Luly Jay R. (President and CEO) Sale 15,000 34.03 510,390
2015-02-20 Luly Jay R. (President and CEO) Sale 15,000 35.35 530,295
2015-02-19 Buckley Stephen Jr. (Director) Buy 600 34.20 20,520
2015-02-18 Buckley Stephen Jr. (Director) Buy 400 33.69 13,476
2015-02-17 Gardiner Nathaniel S. (Sr. VP & General Counsel) Buy 1,000 33.28 33,285
2015-02-13 Gardiner Nathaniel S. (Sr. VP & General Counsel) Buy 400 33.00 13,200
2015-01-16 Mellett Paul J (Treasurer and CFO) Sale 4,500 49.50 222,736
2015-01-06 Or Yat Sun (Chief Scientific Officer) Option Ex 58,004 1.21 70,010
2015-01-05 Luly Jay R. (President and CEO) Sale 15,000 50.60 759,060
2014-12-12 Luly Jay R. (President and CEO) Option Ex 7,055 .73 5,171
2014-12-01 Luly Jay R. (President and CEO) Sale 15,000 45.98 689,625
2014-11-28 Mellett Paul J (Treasurer and CFO) Sale 6,000 47.87 287,196
2014-11-03 Luly Jay R. (President and CEO) Sale 15,000 42.71 640,680
2014-10-20 Mellett Paul J (Treasurer and CFO) Sale 4,000 45.30 181,180
2014-09-15 Mellett Paul J (Treasurer and CFO) Sale 10,000 40.16 401,629
2014-08-14 Buckley Stephen Jr. (Director) Buy 1,000 38.95 38,950
2014-08-14 Mellett Paul J (Treasurer and CFO) Sale 10,000 39.13 391,280
2014-08-13 Or Yat Sun (Chief Scientific Officer) Sale 5,000 39.76 198,795
2014-08-05 Or Yat Sun (Chief Scientific Officer) Option Ex 11,149 1.29 14,415
2014-07-14 Mellett Paul J (Treasurer and CFO) Sale 20,000 40.16 803,180
2014-07-01 Or Yat Sun (Chief Scientific Officer) Sale 5,000 42.59 212,935
2014-06-02 Or Yat Sun (Chief Scientific Officer) Sale 5,000 37.76 188,800
2014-05-01 Or Yat Sun (Chief Scientific Officer) Sale 5,000 36.76 183,795
2014-04-01 Or Yat Sun (Chief Scientific Officer) Sale 10,000 39.95 399,450
2014-04-01 Luly Jay R. (President and CEO) Sale 15,000 39.95 599,250
2014-03-24 Or Yat Sun (Chief Scientific Officer) Sale 10,000 39.48 394,780
2014-03-12 Mellett Paul J (Treasurer and CFO) Option Ex 92,132 .73 67,532
2014-03-10 Luly Jay R. (President and CEO) Sale 10,000 38.56 385,650
2014-03-04 Schuhsler Helmut (10% Owner) Sale 430,263 38.82 16,701,088
2014-03-03 Schuhsler Helmut (10% Owner) Sale 9,071 38.83 352,263
2014-02-26 Schuhsler Helmut (10% Owner) Sale 53,589 39.93 2,139,862
2014-02-25 Schuhsler Helmut (10% Owner) Sale 176,601 38.92 6,873,134
2014-02-24 Goll Alexandra (10% Owner) Sale 52,597 39.51 2,078,054
2014-02-24 Schuhsler Helmut (Director) Sale 52,597 39.51 2,078,054
2014-02-21 Goll Alexandra (10% Owner) Sale 7,880 40.00 315,200
2014-02-21 Schuhsler Helmut (Director) Sale 7,880 40.00 315,200
2014-02-18 Goll Alexandra (10% Owner) Sale 10,000 40.19 401,850
2014-02-18 Schuhsler Helmut (Director) Sale 13,000 40.32 524,147
2014-02-14 Luly Jay R. (President and CEO) Sale 5,800 38.16 221,339
2014-01-10 Luly Jay R. (President and CEO) Option Ex 251,119 .73 184,070
2014-01-03 Or Yat Sun (Chief Scientific Officer) Option Ex 129,087 .73 94,620
2014-01-02 Luly Jay R. (President and CEO) Sale 5,800 28.19 163,507
2013-12-11 Afting Ernst-guenter (Director) Sale 15,000 37.16 557,460
2013-12-06 Goldberg Marc E. (Director) Sale 6,861 27.93 191,614
2013-11-27 Goldberg Marc E. (Director) Sale 15,554 26.08 405,601
2013-11-26 Goldberg Marc E. (Director) Sale 34,446 25.61 882,127
2013-10-14 Obp Iii - Holdings Llc (10% Owner) Sale 32,103 19.83 636,570
2013-10-11 Obp Iii - Holdings Llc (10% Owner) Sale 198 21.05 4,167
2013-10-10 Obp Iii - Holdings Llc (10% Owner) Sale 11,207 21.06 235,974
2013-10-09 Obp Iii - Holdings Llc (10% Owner) Sale 25,000 22.00 550,000
2013-10-03 Saints Capital Granite, Llc (10% Owner) Sale 4,100 22.85 93,668
2013-10-02 Saints Capital Granite, Llc (10% Owner) Sale 8,200 23.66 193,995
2013-10-01 Obp Iii - Holdings Llc Sale 185,700 23.54 4,371,563
2013-09-30 Obp Iii - Holdings Llc Sale 14,300 23.13 330,759
2013-07-11 Mellett Paul J (Treasurer and CFO) Option Ex 84,265 .73 61,766
2013-03-26 Obp Iii - Holdings Llc (10% Owner) Buy 66,474 14.00 930,636
2013-03-26 Verdine Gregory L. (Director) Buy 3,324 14.00 46,536
2013-03-26 Vance Terry (Director) Buy 13,295 14.00 186,130
2013-03-26 Goll Alexandra (10% Owner) Buy 132,949 14.00 1,861,286
2013-03-26 Schuhsler Helmut (Director) Buy 132,949 14.00 1,861,286

Insider trading activities including stock purchases, stock sales, and option exercises of ENTA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Enanta Pharmaceuticals Inc (symbol ENTA, CIK number 1177648) see the Securities and Exchange Commission (SEC) website.